Drugs / Budesonide/formoterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01668121 | Aug → Nov 2012 | asthma | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/formoterol | “Budesonide/formoterol Easyhaler” NCT01668121 ↗ |
| Route | Inhaled | “Device-metered Dry Powder Inhalers” NCT01668121 ↗ |